Gimv
Gimv makes 1.3x return on divestments for 2012/13
Gimv has announced a 1.3x return on divestments, relative to original acquisition value, for the year ending in March 2013.
Gimv sells stake in Halder
Belgian private equity firm Gimv has handed back its stake in fellow German private equity house Halder to the GP.
Gimv’s Verbinnen winds up
Gimv-backed Belgian food processing business Verbinnen Poultry Group has filed a petition to wind up on 25 February 2013 after failing to find a buyer.
Gimv launches Health & Care Fund
Gimv has launched a new €200m fund focused on healthcare and medical technology investments.
Gimv et al. invest €5.5m in pharma company Multiplicom
Gimv and regional Belgian players have invested €5.5m in Antwerp-based biotechnology company Multiplicom NV.
CDC leads €10m round for McPhy Energy
CDC Entreprises has invested €5m as part of a €10m round for French hydrogen storage specialist McPhy Energy.
Gimv et al. invest €5m in biotech startup AgroSavfe
Gimv has led a €5m investment in Belgian green crop protection products business AgroSavfe, alongside regional funds PMV, Sofi, QBIC and VIB.
Gimv buys ProxiAD from UI Gestion
Gimv has acquired a majority stake in French software engineering services provider ProxiAD from UI Gestion.
Gimv takes loss on Salsa Food Group
Gimv has sold its shares in Belgian ready-made salad company Salsa Food Group to private equity-backed SaladSignature, a producer of refrigerated spreadable salads and convenience food.
Gimv and Iris Capital sell stake in Human Inference
Gimv and Iris Capital have sold their share of Dutch data management solutions provider Human Inference to French trade buyer Neopost.
Gimv sells Mentum to InfoVista
Gimv has sold its stake in French software provider Mentum to network solutions company InfoVista after a 10-year holding period.
NGN Capital et al. in $40.3m Endosense series-C round
NGN Capital and a syndicate of existing investors have backed Swiss medical technology company Endosense with $40.3m in a series-C funding round.
Gimv reshapes strategy to boost future growth
Belgian GP Gimv has announced an overhaul of its strategic orientation and management team, in order to strengthen its position in the industry.
Gimv leads €10m round for GOVECS
European private equity firm Gimv has led a €10m financing round for Munich-based electric scooter company GOVECS.
Intel Capital leads €6.5m series-C for Movea
Intel Capital has led a €6.5m series-C funding round for French technology firm Movea.
Gimv acquires 25% stake in ARS T&TT
Gimv has invested growth capital in Dutch transportation services provider ARS T&TT in exchange for a 25% equity stake.
AG Insurance buys into Gimv fund in €65m secondaries deal
AG Insurance has acquired part of the commitment of Vlaamse Participatiemaatschappij (VPM) in the Gimv-XL fund – a deal worth €65m.
Gimv invests £5.7m in series-B round for Prosonix
Gimv has committed £5.7m to the second closing of a series-B financing round, now totalling £17.1m, for UK-based pharma Prosonix.
Gimv sells stake in Belgian recruitment agency to Naxicap
Gimv has sold its minority stake in Belgian recruitment and selection agency Accent Jobs to Naxicap.
Gimv leads €5.4m capital increase in NovoPolymers NV
Gimv, Capricorn Cleantech Fund and new investor SFPI-FPIM have joined forces to increase the capital base of cleantech firm NovoPolymers by €5.4m.
Gimv leads €6m funding round in GreenWatt
Gimv, Innogy Venture Capital, SRIW and existing investors have committed €6m of capital to fund the expansion of Belgian alternative energy company GreenWatt.
DG Infra Yield acquires 80.1% in special purposes vehicle
The joint infrastructure fund of Gimv and Dexia Bank Belgium has acquired 80.1% of OPTIMEP 4.
Gimv increases majority stake in VCST
Gimv has acquired LRM's stake in VCST and increased its majority holding to 79.8% of the company.
Gimv sells part of Tinubu Square stake
Gimv has sold the largest part of its minority stake in French credit risk solutions provider Tinubu Square to sovereign wealth fund FSI.